23.4.2021 14:49:41 CEST | Demant A/S |
Antal stemmerettigheder og kapital
Selskabsmeddelelse nr. 2021-06
23. april 2021
Gennemførelse af kapitalnedsættelse i Demant A/S
Som oplyst i selskabsmeddelelse nr. 2021-04 blev det på Demant A/S’ ordinære generalforsamling den 5. marts 2021 besluttet at nedsætte selskabets aktiekapital med nominelt DKK 112.667 fordelt på 563.335 aktier a DKK 0,20 svarende til selskabets beholdning af egne aktier pr. 10. februar 2021 fraregnet aktier til dækning af ledelsens fastholdelsesprogram og medarbejdernes aktielønsordning.
Offentliggørelse af kapitalnedsættelsen har fundet sted i Erhvervsstyrelsens it-system den 18. marts 2021. Proklamafristen er udløbet uden indsigelser. Kapitalnedsættelsen er derfor anmeldt endeligt til Erhvervsstyrelsen. Efter kapitalnedsættelsen udgør aktiekapitalen i Demant A/S nominelt DKK 48.025.566,60.
I henhold til § 32 i lov om kapitalmarkeder oplyses det hermed, at selskabets samlede aktiekapital og samlede antal stemmerettigheder er opgjort til:
Aktiekapital (nominelt): DKK 48.025.566,60
Antal stemmerettigheder: 240.127.833
Yderligere information:
Adm. direktør Søren Nielsen
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
CFO René Schneider
IR-chef Mathias Holten Møller
IR Officer Christian Lange
Kommunikationschef Trine Kromann-Mikkelsen
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2021-06 Gennemførelse af kapitalnedsættelse.pdf
23.4.2021 14:49:41 CEST | Demant A/S |
Total number of voting rights and capital
Company announcement no 2021-06
23 April 2021
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2021-04, it was decided at Demant A/S’ ordinary general meeting on 5 March 2021 to reduce the company’s share capital by nominally DKK 112,667 divided into 563,335 shares of DKK 0.20, corresponding to the company’s holding of treasury shares at 10 February 2021 with the deduction of shares to cover Management’s retention programme and the employee share salary arrangement.
The capital reduction was published in the electronic information system of the Danish Business Authority on 18 March 2021. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 48,025,566.60.
In accordance with Section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 48,025,566.60
Number of voting rights: 240,127,833
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Mathias Holten Møller, Head of IR
Christian Lange, IR Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2021-06 Completion of capital reduction.pdf
